In luminal models, MYC appears to be involved in the regulation of metabolic pathways downstream of β-catenin and ERα signaling, thus associating the metabolic characteristics of intrinsic breast cancer subtypes on their ER expression. The gene discussed is MYC; the disease is breast cancer.